Actionable news
All posts from Actionable news
Actionable news in MYOK: MyoKardia Inc,

MyoKardia shares surge 32% on positive mid-stage trial results for heart muscle disease

MyoKardia Inc. MYOK, +2.39% shares surged 31.8% in premarket trade Monday on positive mid-stage clinical trial results for its mavacamten therapy. Patients on the therapy met the trial's primary endpoint and key secondary endpoints in the phase 2 trial, the company said. MyoKardia expects to start its next clinical trial by the end of this year, depending on discussions with the Food and Drug...